Variant report
Variant | nsv523536 |
---|---|
Chromosome Location | chr13:79820126-79824974 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:78711468..78712020-chr13:79820783..79821405,2 | MCF-7 | breast: | |
2 | chr13:79552590..79553146-chr13:79820455..79821175,2 | MCF-7 | breast: | |
3 | chr13:79822200..79824938-chr13:79835145..79837970,2 | K562 | blood: | |
4 | chr13:79822200..79826014-chr13:79835066..79837970,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7339418 | chr13:79820126-79820127 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186039274 | chr13:79820154-79820155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569616616 | chr13:79820166-79820167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141138120 | chr13:79820194-79820195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531612353 | chr13:79820231-79820232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575195859 | chr13:79820258-79820259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558023609 | chr13:79820281-79820282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74404890 | chr13:79820348-79820349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189709404 | chr13:79820403-79820404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7316975 | chr13:79820428-79820429 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs559434557 | chr13:79820439-79820440 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368104033 | chr13:79820489-79820490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572819014 | chr13:79820519-79820520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143234846 | chr13:79820568-79820569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183397313 | chr13:79820577-79820578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541182736 | chr13:79820597-79820598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11353378 | chr13:79820599-79820600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187689070 | chr13:79820636-79820637 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550933748 | chr13:79820668-79820669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7321701 | chr13:79820675-79820676 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs192329154 | chr13:79820705-79820706 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546460753 | chr13:79820711-79820712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112235189 | chr13:79820712-79820713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188388696 | chr13:79820757-79820758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147497115 | chr13:79820759-79820760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528762982 | chr13:79820760-79820761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140200228 | chr13:79820778-79820779 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548977023 | chr13:79820800-79820801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370619331 | chr13:79820850-79820851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528017740 | chr13:79820853-79820854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568953575 | chr13:79820863-79820864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563807931 | chr13:79820870-79820871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192645302 | chr13:79820885-79820886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558058409 | chr13:79820922-79820923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12428306 | chr13:79820927-79820928 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs534421585 | chr13:79820932-79820933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200144350 | chr13:79820978-79820979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554046085 | chr13:79820998-79820999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184791035 | chr13:79821024-79821025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145705999 | chr13:79821025-79821026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368375782 | chr13:79821026-79821027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555492179 | chr13:79821100-79821101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575355160 | chr13:79821136-79821137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117406725 | chr13:79821149-79821150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532615340 | chr13:79821174-79821175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188224360 | chr13:79821248-79821249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533042407 | chr13:79821250-79821251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540427754 | chr13:79821272-79821273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560051390 | chr13:79821280-79821281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs77257836 | chr13:79821301-79821302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 21364760 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Schizophrenia | 19197363 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:79817600-79820200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:79817600-79824400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr13:79819800-79820600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr13:79819800-79821000 | Enhancers | GM12878-XiMat | blood |
5 | chr13:79820000-79821000 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr13:79820200-79820600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr13:79820200-79820800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr13:79820200-79820800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr13:79820400-79820800 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr13:79820800-79821000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr13:79820800-79824600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr13:79824400-79824800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr13:79824400-79825000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr13:79824600-79825000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr13:79824600-79825000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr13:79824600-79825000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr13:79824600-79825200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr13:79824600-79825200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |